Private Capital Management (Colorado)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Private Capital Management (Colorado)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$21.6K	Hold	240	–	–	﹤0.01%	189
2024 Q3	$23.7K	Hold	240	–	–	﹤0.01%	257
2024 Q2	$22.3K	Sell	240 -3	-1%	-$269	﹤0.01%	209
2024 Q1	$23.1K	Hold	243	–	–	0.01%	217
2023 Q4	$21.7K	Buy	243 +3	+1%	+$223	0.01%	196
2023 Q3	$17.5K	Hold	240	–	–	0.01%	193
2023 Q2	$20K	Hold	240	–	–	0.01%	181
2023 Q1	$18.3K	Buy	+240	New	+$19.9K	0.01%	190

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Private Capital Management (Colorado)'s XBI Position: Q4 2024 in Review

Private Capital Management (Colorado) held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q4 2024 at 240 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #189.

Private Capital Management (Colorado) first reported a position in XBI in Q1 2023 and has held it in 8 quarters since. The position peaked at $23.7K in Q3 2024. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

Private Capital Management (Colorado) held 240 shares of State Street SPDR S&P Biotech ETF worth $21.6K as of Q4 2024.
Private Capital Management (Colorado) left its State Street SPDR S&P Biotech ETF share count unchanged in Q4 2024.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Private Capital Management (Colorado)'s portfolio in Q4 2024, its #189 holding.
Private Capital Management (Colorado) first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and has held it in 8 quarters since.
Private Capital Management (Colorado)'s State Street SPDR S&P Biotech ETF position peaked at $23.7K in Q3 2024.
738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Private Capital Management (Colorado)'s 13F filing for Q4 2024, filed 5 Feb 2025.